GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Henry Schein Inc (NAS:HSIC) » Definitions » Days Sales Outstanding

HSIC (Henry Schein) Days Sales Outstanding : 44.07 (As of Mar. 2025)


View and export this data going back to 1995. Start your Free Trial

What is Henry Schein Days Sales Outstanding?

Henry Schein's average Accounts Receivable for the three months ended in Mar. 2025 was $1,530 Mil. Henry Schein's Revenue for the three months ended in Mar. 2025 was $3,168 Mil. Hence, Henry Schein's Days Sales Outstanding for the three months ended in Mar. 2025 was 44.07.

The historical rank and industry rank for Henry Schein's Days Sales Outstanding or its related term are showing as below:

HSIC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 39.18   Med: 46.16   Max: 57.05
Current: 45.65

During the past 13 years, Henry Schein's highest Days Sales Outstanding was 57.05. The lowest was 39.18. And the median was 46.16.

HSIC's Days Sales Outstanding is ranked better than
79.09% of 110 companies
in the Medical Distribution industry
Industry Median: 75.245 vs HSIC: 45.65

Henry Schein's Days Sales Outstanding declined from Mar. 2024 (50.44) to Mar. 2025 (44.07).


Henry Schein Days Sales Outstanding Historical Data

The historical data trend for Henry Schein's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Henry Schein Days Sales Outstanding Chart

Henry Schein Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 48.17 42.34 41.76 48.88 48.17

Henry Schein Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.44 46.60 46.27 44.92 44.07

Competitive Comparison of Henry Schein's Days Sales Outstanding

For the Medical Distribution subindustry, Henry Schein's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Henry Schein's Days Sales Outstanding Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Henry Schein's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Henry Schein's Days Sales Outstanding falls into.


;
;

Henry Schein Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Henry Schein's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

Days Sales Outstanding (A: Dec. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Dec. 2024 )) / count ) / Revenue (A: Dec. 2024 )*Days in Period
=( (1863 + 1482) / 2 ) / 12673*365
=1672.5 / 12673*365
=48.17

Henry Schein's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding (Q: Mar. 2025 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2024 ) + Accounts Receivable (A: Mar. 2025 )) / count ) / Revenue (A: Mar. 2025 )*Days in Period
=( (1482 + 1578) / 2 ) / 3168*365 / 4
=1530 / 3168*365 / 4
=44.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Henry Schein  (NAS:HSIC) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Henry Schein Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Henry Schein's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Henry Schein Business Description

Address
135 Duryea Road, Melville, NY, USA, 11747
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are global Distribution and Value-Added Services; global Specialty Products; and global Technology. It generates the majority of its revenue from the global Distribution and Value-Added Services segment which includes distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
Executives
Bradford C Connett officer: CEO, NA Distribution Group C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Philip A Laskawy director 9 CREAMER HILL ROAD, GREENWICH CT 06831
Kurt P Kuehn director C/O HENRY SCHEIN, INC, 135 DURYEA ROAD, MELVILLE NY 11747
Michael S Ettinger officer: SVP, General Counsel, Sec. C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Lorelei Mcglynn officer: SVP, Global HR & Fin. Oper. C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Mark E Mlotek director, officer: SVP, Corp Bus Dev Group C/O HENRY SCHEIN INC, 135 DURYEA RD, MELVILLE NY 11747
Walter Siegel officer: Senior VP & General Counsel C/O HENRY SCHEIN, INC, 135 DURYEA RD, MELVILLE NY 11747
James P Breslawski director, officer: Executive Vice President C/O HENRY SCHEIN INC, 135 DURYEA RD, MELVILLE NY 11747
Stanley M Bergman director, officer: President and CEO C/O HENRY SCHEIN INC, 135 DURYEA ROAD, MELVILLE NY 11747
Brous David B Jr officer: CEO, Strategic Business Group C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Gerald A Benjamin director, officer: Executive V.P and CAO C/O HENRY SCHEIN, INC, 135 DURYEA RD, MELVILLE NY 11747
Ronald N. South officer: SVP & Chief Financial Officer C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Scott Philip Serota director C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Reed Vaughn Tuckson director C/O UNITEDHEALTH GROUP INCORPORATED, 9900 BREN ROAD EAST, MINNETONKA MN 55123
Steven Paladino director, officer: Executive V.P. and CFO C/O HENRY SCHEIN INC, 135 DURYEA RD, MELVILLE NY 11747